# Dyslipidemia in Cardiovascular Disease

> **NCT01029522** · PHASE4 · COMPLETED · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 244 (actual)

## Conditions studied

- Dyslipidemia

## Interventions

- **DRUG:** Atorvastatin (Lipilou)
- **DRUG:** Atorvastatin (Lipitor)

## Key facts

- **NCT ID:** NCT01029522
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2008-10
- **Final completion:** 2009-11
- **Target enrollment:** 244 (ACTUAL)
- **Last updated:** 2012-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01029522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01029522, "Dyslipidemia in Cardiovascular Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01029522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*